Neurotechnology Market Research Reveals Path To $33.63 Billion By 2030

The neurotechnology sector is on the brink of remarkable expansion, driven by advances in diagnostics, therapies, and brain-machine interfaces. As the demand for personalized neurological care and innovative treatment methods rises, this market is positioned to achieve substantial growth over the coming years. Let's explore the market's anticipated size, key players, emerging trends, and segmentation to understand what the future holds for neurotechnology.

Forecasted Growth and Market Size of the Neurotechnology Industry
The neurotechnology market is projected to grow substantially, reaching a value of $33.64 billion by 2030. This expansion is expected at a compound annual growth rate (CAGR) of 14.1%. Several factors contribute to this growth, including increased investment in brain-computer interface technologies, a rising need for personalized neurological therapies, broader adoption of AI-driven diagnostic tools, and the growing use of home-based neurotechnology devices. Additionally, the development of minimally invasive neurotherapies is further catalyzing market growth. Key trends shaping this landscape include the proliferation of brain-computer interface solutions, wider acceptance of non-invasive neurostimulation devices, enhanced integration of neuroimaging within clinical settings, increased demand for cognitive rehabilitation technologies, and advancements in the materials used for neurological implants.

The neurotechnology market size has grown rapidly in recent years. It will grow from $17.34 billion in 2025 to $19.84 billion in 2026 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to advancements in medical imaging technologies, early adoption of neurostimulation therapies, increasing clinical research in neurology, rising prevalence of neurological disorders, technological progress in implantable devices.

Download a free sample of the neurotechnology market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9840&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Corporations Driving the Neurotechnology Market
The neurotechnology space features a range of prominent companies contributing to its rapid development. Notable market participants include General Electric, Medtronic PLC, Koninklijke Philips N.V., Shimadzu Corporation, Elekta AB, Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., Neurotech Pharmaceuticals Inc., Neuralink, Synchron Inc., Blackrock Neurotech, Neuronetics Inc., and Neurable Inc.

Significant Market Activity and Strategic Acquisitions
In a recent strategic move, electroCore, a US-based provider specializing in non-invasive bioelectronic and neuromodulation therapies, acquired NeuroMetrix in May 2025 for an undisclosed sum. This acquisition is designed to enhance electroCore's neurotechnology offerings and accelerate its commercial reach by incorporating NeuroMetrix's cloud-enabled wearable neuromodulation platform. NeuroMetrix is known for its app-connected wearable devices targeting conditions such as fibromyalgia and chronic pain, along with diagnostic tools for neuropathic disorders, positioning electroCore to solidify its presence in chronic pain management solutions.

View the full neurotechnology market report:
https://www.thebusinessresearchcompany.com/report/neurotechnology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovations and Future Directions in Neurotechnology
Industry leaders are focusing on cutting-edge therapeutic technologies, such as the endovascular brain-computer interface (BCI), aimed at improving cognitive function and restoring mobility in patients with neurological impairments. This endovascular BCI enables direct access to neural signals via blood vessels, creating new possibilities for patient interaction and treatment. For example, in April 2024, the Sweden-based software firm Synchron introduced a Patient Registry for its Stentrode Brain-Computer Interface system. The Stentrode BCI is designed to decode brain signals and translate motor intent, allowing individuals with severe mobility limitations to control digital devices hands-free. Implanted through a minimally invasive endovascular procedure, this device wirelessly transmits neural information, enabling users to regain independence in communication and essential daily activities. This breakthrough represents a major advancement in assistive technology that can significantly improve quality of life.

Comprehensive Breakdown of the Neurotechnology Market Segmentation
The neurotechnology market is categorized into several key segments as follows:
1) By Conditions Treated:
- Cognitive Disorders
- Pain Treatment
- Urinary And Fecal Incontinence
- Epilepsy
- Parkinson's Disease
- Hearing Conditions
- Sleep Disorder
- Depression
- Other Conditions
2) By Technology Type:
- Imaging Modalities
- Neurostimulation
- Cranial Surface Measurement
- Neurological Implants
- Other Types
3) By End-Use Settings:
- Ambulatory Surgical Centers
- Hospitals
- Homecare Facilities
- Other End Uses

Further detailed subsegments include:
- Cognitive Disorders such as Alzheimer's Disease, ADHD, and Dementia
- Pain Treatment subcategories including Chronic Pain, Neuropathic Pain, and Acute Pain
- Urinary and Fecal Incontinence treatments like Overactive Bladder, Neurogenic Bladder, and Fecal Incontinence Management
- Epilepsy with Drug-Resistant Epilepsy and Seizure Management Devices
- Parkinson's Disease addressing Motor and Non-Motor Symptoms
- Hearing Conditions covering Tinnitus and Hearing Loss Solutions
- Sleep Disorders such as Insomnia, Sleep Apnea, and Restless Legs Syndrome
- Depression including Major Depressive Disorder and Treatment-Resistant Depression
- Other Conditions including Anxiety Disorders, Autism Spectrum Disorder, and Traumatic Brain Injury (TBI)

This detailed segmentation highlights the wide-ranging scope and depth of the neurotechnology market, underscoring its potential to transform various aspects of neurological healthcare.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.